Oral Delivery of Large Molecules

Investor

Overview

SEC Filing Details

Document Details

Form
6-K
Filing Date
Nov 10, 2021
Document Date
Nov 10, 2021
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.